Sisu Global Hemafuse
Sisu Global Health
The Sisu Global Hemafuse is a manual autotransfusion device is that used to retransfuse a patient’s own blood during an internal hemorrhage. The Hemafuse is in early-stage development and undergoing field trials.
Sub-Saharan Africa countries- Ghana, Rwanda, Kenya, Tanzania, and Ethiopia
Hospitals, NGO, governments will buy Sisu Global Hemafuse from Sisu and distribute.
The Hemafuse body is projected to cost $50 retail for 50 uses. Each filter is designed to cost $10 retail, and is disposable after each patient. The cost for these filters will be passed onto the patient or to the national health insurance scheme
Direct transfusion via widely used manual procedure commonly used in Sub-Saharan Africa which consists of salvaging blood with a kitchen soup ladle and filtering it with gauze, Cell processors and salvage devices. Devices include: Transflow, Transmed Transfusion Devices, Haemonetics® Cell Saver®, Medtronic autoLog, Fenwal Transfusion set, Beldico Transfusion set, Bicakcilar transfusion set
For use by health care providers for patients with internal hemorrhaging specifically due to ectopic pregnancies or auto accidents.
Small-batch medical device production.
The Hemafuse will be available for purchase directly from Sisu by hospital administrators, medical NGO’s, and Ministries of Health.
Prototype. Not available on the market as yet.
The Hemafuse is a manual autotransfusion device that functions much like a large syringe to pull blood through a filter and to transport it straight to a blood bag in a closed system. The process is illustrated in the image below. One filter for the Hemafuse can transfuse up to four or five pints of blood.
Surgeons are trained, Sisu provides training and support.
Filters are available separately, unknown if other parts are available separately
Each patient receives a new filter, but the device can be used up to 50 times before needing to be replaced.
Sisu claims that the Hemafuse takes 1/3 of the time, 1/9 of the staff, and is significantly safer than the traditional soup ladle procedure.
Pre-Clinical testing is currently underway, clinical (human) testing is to be started in late 2015.
Ectopic Pregnancies and Intraoperative Autotransfusion Jennifer Laskey, BSc Philip B Wood, MB FRCS Department of Surgery, ELWA Hospital, Box 10–0192 Monrovia, Liberia. doi: 10.1177/004947559102100308
Priuli, G., Darate, R., Perrin, R. X., Lankoande, J. and Drouet, N. (2009), Multicentre experience with a simple blood salvage technique in patients with ruptured ectopic pregnancy in sub-Sahelian West Africa. Vox Sanguinis, 97: 317–323. doi: 10.1111/j.1423-0410.2009.001215.x
None indicated. Applicable international standards are unknown.
Field trials tracking parameters such as time required, number of staff required, safety and cleanliness.
In context photographs (0)
You can use the form below to contribute a photo of this product.
In context files & documents (0)
Feedback from users, customers & distributors
Please let us know your experience in using this product through comments below.